Global and United States Osimertinib Market Report & Forecast 2024-2031

Report ID: 1869207 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Osimertinib Product Introduction
    1.2 Global Osimertinib Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Osimertinib Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Osimertinib Sales in Volume for the Year 2017-2028
    1.3 United States Osimertinib Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Osimertinib Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Osimertinib Sales in Volume for the Year 2017-2028
    1.4 Osimertinib Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Osimertinib in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Osimertinib Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Osimertinib Market Dynamics
        1.5.1 Osimertinib Industry Trends
        1.5.2 Osimertinib Market Drivers
        1.5.3 Osimertinib Market Challenges
        1.5.4 Osimertinib Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Osimertinib Market Segment by Type
        2.1.1 40mg*30 Tablets
        2.1.2 80mg*30 Tablets
        2.1.3 40mg*10 Tablets
        2.1.4 80mg*10 Tablets
    2.2 Global Osimertinib Market Size by Type
        2.2.1 Global Osimertinib Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Osimertinib Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Osimertinib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Osimertinib Market Size by Type
        2.3.1 United States Osimertinib Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Osimertinib Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Osimertinib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Osimertinib Market Segment by Application
        3.1.1 Locally Advanced NSCLC
        3.1.2 Metastatic NSCLC
        3.1.3 Other
    3.2 Global Osimertinib Market Size by Application
        3.2.1 Global Osimertinib Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Osimertinib Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Osimertinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Osimertinib Market Size by Application
        3.3.1 United States Osimertinib Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Osimertinib Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Osimertinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Osimertinib Competitor Landscape by Company
    4.1 Global Osimertinib Market Size by Company
        4.1.1 Top Global Osimertinib Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Osimertinib Revenue by Manufacturer (2017-2022)
        4.1.3 Global Osimertinib Sales by Manufacturer (2017-2022)
        4.1.4 Global Osimertinib Price by Manufacturer (2017-2022)
    4.2 Global Osimertinib Concentration Ratio (CR)
        4.2.1 Osimertinib Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Osimertinib in 2021
        4.2.3 Global Osimertinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Osimertinib Manufacturing Base Distribution, Product Type
        4.3.1 Global Osimertinib Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Osimertinib Product Type
        4.3.3 Date of International Manufacturers Enter into Osimertinib Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Osimertinib Market Size by Company
        4.5.1 Top Osimertinib Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Osimertinib Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Osimertinib Sales by Players (2020, 2021 & 2022)
5 Global Osimertinib Market Size by Region
    5.1 Global Osimertinib Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Osimertinib Market Size in Volume by Region (2017-2028)
        5.2.1 Global Osimertinib Sales in Volume by Region: 2017-2022
        5.2.2 Global Osimertinib Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Osimertinib Market Size in Value by Region (2017-2028)
        5.3.1 Global Osimertinib Sales in Value by Region: 2017-2022
        5.3.2 Global Osimertinib Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Osimertinib Market Size YoY Growth 2017-2028
        6.1.2 North America Osimertinib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Osimertinib Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Osimertinib Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Osimertinib Market Size YoY Growth 2017-2028
        6.3.2 Europe Osimertinib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Osimertinib Market Size YoY Growth 2017-2028
        6.4.2 Latin America Osimertinib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Osimertinib Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Osimertinib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Corporation Information
        7.1.2 AstraZeneca Description and Business Overview
        7.1.3 AstraZeneca Osimertinib Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 AstraZeneca Osimertinib Products Offered
        7.1.5 AstraZeneca Recent Development
    7.2 Incepta Pharmaceuticals Limited
        7.2.1 Incepta Pharmaceuticals Limited Corporation Information
        7.2.2 Incepta Pharmaceuticals Limited Description and Business Overview
        7.2.3 Incepta Pharmaceuticals Limited Osimertinib Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Incepta Pharmaceuticals Limited Osimertinib Products Offered
        7.2.5 Incepta Pharmaceuticals Limited Recent Development
    7.3 Everest Pharmaceuticals
        7.3.1 Everest Pharmaceuticals Corporation Information
        7.3.2 Everest Pharmaceuticals Description and Business Overview
        7.3.3 Everest Pharmaceuticals Osimertinib Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Everest Pharmaceuticals Osimertinib Products Offered
        7.3.5 Everest Pharmaceuticals Recent Development
    7.4 Beacon Pharma
        7.4.1 Beacon Pharma Corporation Information
        7.4.2 Beacon Pharma Description and Business Overview
        7.4.3 Beacon Pharma Osimertinib Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Beacon Pharma Osimertinib Products Offered
        7.4.5 Beacon Pharma Recent Development
    7.5 Drug International
        7.5.1 Drug International Corporation Information
        7.5.2 Drug International Description and Business Overview
        7.5.3 Drug International Osimertinib Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Drug International Osimertinib Products Offered
        7.5.5 Drug International Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Osimertinib Industry Chain Analysis
    8.2 Osimertinib Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Osimertinib Distributors
    8.3 Osimertinib Production Mode & Process
    8.4 Osimertinib Sales and Marketing
        8.4.1 Osimertinib Sales Channels
        8.4.2 Osimertinib Distributors
    8.5 Osimertinib Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Osimertinib CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Osimertinib Market Trends
    Table 3. Osimertinib Market Drivers
    Table 4. Osimertinib Market Challenges
    Table 5. Osimertinib Market Restraints
    Table 6. Global Osimertinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Osimertinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Osimertinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Osimertinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Osimertinib Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Osimertinib Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Osimertinib Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Osimertinib Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Osimertinib Sales Share by Manufacturer, 2017-2022
    Table 15. Global Osimertinib Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Osimertinib Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Osimertinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osimertinib as of 2021)
    Table 18. Top Players of Osimertinib in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Osimertinib Product Type
    Table 20. Date of International Manufacturers Enter into Osimertinib Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Osimertinib Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Osimertinib Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Osimertinib Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Osimertinib Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Osimertinib Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Osimertinib Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Osimertinib Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Osimertinib Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Osimertinib Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Osimertinib Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Osimertinib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Osimertinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Osimertinib Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Osimertinib Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Osimertinib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Osimertinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Osimertinib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Osimertinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Osimertinib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Osimertinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AstraZeneca Corporation Information
    Table 43. AstraZeneca Description and Business Overview
    Table 44. AstraZeneca Osimertinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. AstraZeneca Osimertinib Product
    Table 46. AstraZeneca Recent Development
    Table 47. Incepta Pharmaceuticals Limited Corporation Information
    Table 48. Incepta Pharmaceuticals Limited Description and Business Overview
    Table 49. Incepta Pharmaceuticals Limited Osimertinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Incepta Pharmaceuticals Limited Product
    Table 51. Incepta Pharmaceuticals Limited Recent Development
    Table 52. Everest Pharmaceuticals Corporation Information
    Table 53. Everest Pharmaceuticals Description and Business Overview
    Table 54. Everest Pharmaceuticals Osimertinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Everest Pharmaceuticals Product
    Table 56. Everest Pharmaceuticals Recent Development
    Table 57. Beacon Pharma Corporation Information
    Table 58. Beacon Pharma Description and Business Overview
    Table 59. Beacon Pharma Osimertinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Beacon Pharma Product
    Table 61. Beacon Pharma Recent Development
    Table 62. Drug International Corporation Information
    Table 63. Drug International Description and Business Overview
    Table 64. Drug International Osimertinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Drug International Product
    Table 66. Drug International Recent Development
    Table 67. Key Raw Materials Lists
    Table 68. Raw Materials Key Suppliers Lists
    Table 69. Osimertinib Customers List
    Table 70. Osimertinib Distributors List
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Osimertinib Product Picture
    Figure 2. Global Osimertinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Osimertinib Market Size 2017-2028 (US$ Million)
    Figure 4. Global Osimertinib Sales 2017-2028 (K Pcs)
    Figure 5. United States Osimertinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Osimertinib Market Size 2017-2028 (US$ Million)
    Figure 7. United States Osimertinib Sales 2017-2028 (K Pcs)
    Figure 8. United States Osimertinib Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Osimertinib Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Osimertinib Report Years Considered
    Figure 11. Product Picture of 40mg*30 Tablets
    Figure 12. Product Picture of 80mg*30 Tablets
    Figure 13. Product Picture of 40mg*10 Tablets
    Figure 14. Product Picture of 80mg*10 Tablets
    Figure 15. Global Osimertinib Market Share by Type in 2022 & 2028
    Figure 16. Global Osimertinib Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Osimertinib Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Osimertinib Sales by Type (2017-2028) & (K Pcs)
    Figure 19. Global Osimertinib Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Osimertinib Price by Type (2017-2028) & (USD/Pcs)
    Figure 21. United States Osimertinib Market Share by Type in 2022 & 2028
    Figure 22. United States Osimertinib Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Osimertinib Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Osimertinib Sales by Type (2017-2028) & (K Pcs)
    Figure 25. United States Osimertinib Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Osimertinib Price by Type (2017-2028) & (USD/Pcs)
    Figure 27. Product Picture of Locally Advanced NSCLC
    Figure 28. Product Picture of Metastatic NSCLC
    Figure 29. Product Picture of Other
    Figure 30. Global Osimertinib Market Share by Application in 2022 & 2028
    Figure 31. Global Osimertinib Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Osimertinib Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Osimertinib Sales by Application (2017-2028) & (K Pcs)
    Figure 34. Global Osimertinib Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Osimertinib Price by Application (2017-2028) & (USD/Pcs)
    Figure 36. United States Osimertinib Market Share by Application in 2022 & 2028
    Figure 37. United States Osimertinib Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Osimertinib Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Osimertinib Sales by Application (2017-2028) & (K Pcs)
    Figure 40. United States Osimertinib Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Osimertinib Price by Application (2017-2028) & (USD/Pcs)
    Figure 42. North America Osimertinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 43. North America Osimertinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Osimertinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 47. Europe Osimertinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Osimertinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 54. Asia-Pacific Osimertinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Osimertinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 66. Latin America Osimertinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Osimertinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 71. Middle East & Africa Osimertinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Osimertinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Osimertinib Value Chain
    Figure 76. Osimertinib Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Incepta Pharmaceuticals Limited
Everest Pharmaceuticals
Beacon Pharma
Drug International
Frequently Asked Questions
Osimertinib report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Osimertinib report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Osimertinib report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Alectinib

Alectinib market is segmented by region (country), players, by Type and by Application. Players,  ... Read More

Tofacitinib

Tofacitinib market is segmented by region (country), players, by Type and by Application. Players ... Read More